Eye Infection Drugs Market 2028 By Drug Class, Dosage Form, Indications, Causative Agents, End User and Geography | The Insight Partners

report image

Eye Infection Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Antibiotics, Antivirals, Antifungals, Antihistamines, Corticosteroids, Glucocorticoids); Dosage Form (Tablet, Capsule, Ophthalmic Ointment, Eye Drops, Others); Indications (Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye or Sty (Hordeolum), Uveitis, Cellulitis, Ocular herpes); Causative Agents (Virus, Bacteria, Fungus, Allergens); End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography

Report Code: TIPRE00016860 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Viruses, bacteria, or fungi may cause eye infections. Infections of the eye may cause vision changes, discomfort, swelling, discharge, and itching. Several areas of the eye, such as the eyelid, may be affected by infections. Eye infection management includes the use of eye drops, ointments, and oral medicine. Common drug classes used for the treatment of eye infection are aminoglycoside/polypeptide antibiotic combinations, aminoglycoside antibiotic/corticosteroid combinations, aminoglycoside, antibiotic/polypeptide antibiotic/corticosteroid combinations, aminoglycoside antibiotics, macrolide antibiotics, polyene antifungals, polypeptide/antifolate antibiotic combinations, quinolone antibiotics, sulfa antibiotic/corticosteroid combinations, polypeptide antibiotics, sulfa antibiotics, and tetracycline antibiotics.


Factors driving the growth of the eye infection drugs market are the expanding patient pool in hospital pharmacies owing to higher number of eye procedures, coupled with rising products that deal with these infections. However, strict rules & regulations by the government related to the improvement in the system of medication and the treatment with contamination of pharmaceuticals is expected to hamper the growth of the market. Moreover, increasing aged population worldwide and rising prevalence of eye infections in warm climatic conditions and among Afro-Caribbeans, Arabs, and Asians and less frequent among the White populations is anticipated to boost the market growth.


The "Eye Infection Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of eye infection drugs market with detailed market segmentation by drug class, dosage form, indications, causative agents, and distribution channel. The eye infection drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in eye infection drugs market and offers key trends and opportunities in the market.


The eye infection drugs market is segmented on the basis of drug class, dosage form, indications, causative agents, and distribution channel. Based on drug class, the market is segmented as antibiotics, antivirals, antifungals, antihistamines, corticosteroids, and glucocorticoids. On the basis of dosage form, the market is categorized as tablet, capsule, ophthalmic ointment, eye drops, and others. On the basis of indications, the market is categorized as conjunctivitis, keratitis, endophthalmitis, blepharitis, stye or sty (hordeolum), uveitis, cellulitis, and ocular herpes. On the basis of causative agents, the market is categorized as virus, bacteria, fungus, and allergens. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, online pharmacies, and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the eye infection drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The eye infection drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting eye infection drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the eye infection drugs market in these regions.

Get more information on this report :


The report covers key developments in the eye infection drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from eye infection drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for eye infection drugs in the global market. Below mentioned is the list of few companies engaged in the eye infection drugs market.

The report also includes the profiles of key players in eye infection drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis International AG.
  •  Johnson & Johnson
  •  Bausch & Lomb, Inc.
  •  Bayer AG
  •  GlaxoSmithKline plc
  •  Merck & Co., Inc.
  •  Allergan Inc.
  •  Alcon Laboratories Inc
  •  Pfizer, Inc.
  •  Valeant Pharmaceuticals Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Novartis International AG.
2. Johnson & Johnson
3. Bausch & Lomb, Inc.
4. Bayer AG
5. GlaxoSmithKline plc
6. Merck & Co., Inc.
7. Allergan Inc.
8. Alcon Laboratories Inc
9. Pfizer, Inc.
10. Valeant Pharmaceuticals Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount